top of page
OUR FACILITIES
Built for innovative therapeutic programs
The making of a world-class cell & gene therapy facility
Newly-constructed 92,000 square-foot facility
-
42,000 square feet commissioned for clinical GMP in 2023 (~50,000 square feet for future expansion)
-
Seven cleanroom suites in two segregated wings designed for US ISO7 and EU Grade B standards
-
Extensive QC labs supporting environmental monitoring, stability studies, and cell/gene therapy assays, with ability to add more
Designed for cell and gene therapy programs
-
Cell therapy (allogeneic and autologous)
-
Viral vector (retro, lenti, AAV)
-
Critical starting materials (cell isolation, cell banks)
Gene circuit and synthetic biology research center
-
High throughput cell therapy design, optimization, and screening
-
Extensive expertise in cell and gene therapies, including tissue specific promoters for AAV, regulated control of regenerative medicines (iPSC), and logic gates for CAR-T/CAR-NK
bottom of page